Safety of an experimental drug in healthy volunteers
This trial tests a new experimental drug called mRNA-0184, given as an injection under the skin, to see if it is safe and well tolerated in healthy people. It is an early-phase study, so participants will help determine if the drug can move forward to larger trials.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be generally healthy, with no significant ongoing illnesses or conditions.
- Your weight must be between 110 and 220 pounds, and your body mass index (BMI) must be between 18 and 32.
- You must not have any bleeding or wound-healing problems.
- You must not have had a major illness or surgery in the 4 weeks before the study starts.
- You must not be taking any prescription or over-the-counter medications that could affect the study results, except hormonal contraception.
- You must not have participated in another drug trial within 30 days before screening.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine (INCA033989) given as a shot or IV in healthy adults to see how the body processes it and if it's safe.
This early-stage trial tests a new medicine called JMT206 in healthy people to see if it is safe and how the body handles it. Healthy volunteers, ages 18 to 60, are needed to help researchers learn about the drug's effects and how it moves through the body.
This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.
This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.
This is an early-stage safety study testing a new experimental drug called REGN22044 in people with no serious health conditions. Researchers want to understand how safe the drug is, how well people tolerate it, and how the body processes it.
This early-phase study tests a new experimental drug (M5542) in healthy volunteers to see how safe it is and how the body processes a single dose. If you are in good health and meet simple weight and medical history criteria, you may be able to join.
Hear when a new Healthy Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.